🔎 Trials Near Me

Home › Metabolic Syndrome › NCT07401888

A Study Of Milk Consumption In Metabolic Syndrome

Recruiting

Milk Consumption On Cardiovascular Risk Factors In Metabolic Syndrome

Who can join

Ages 18 to 70 · All sexes

Full eligibility criteria
Inclusion Criteria: Presence of 3 of the following risk factors:

1. fasting plasma glucose ≥100 mg/dL (or medical therapy for elevated glucose)
2. HDL-C \<40 mg/dL in men or \<50 mg/dL in women (or medical therapy for reduced HDL-C)
3. Triglycerides ≥150 mg/dL (or medical therapy for elevated triglycerides)
4. Waist circumference \>102 cm for men and \>88 cm for women
5. Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg (or medical therapy for hypertension)

Exclusion Criteria:

1. Cardiovascular disease diagnosis
2. Type 1 or 2 diabetes diagnosis
3. Dairy allergy or lactose intolerance
4. Self-reported high baseline dairy intake (\>3 servings per day)
5. \>3 hours of physical activity per week
6. Pregnant women
7. Inflammatory bowel disease
8. Chronic steroid use
9. Allergy to metal
10. GLP-1 agonist use
11. Patients on medications related to metabolic syndrome where dose adjustments are planned to be made during the study period.

About the study

The primary purpose of this study is to determine the impact of whole-fat dairy consumption on cardiovascular and metabolic risk factors and peripheral vascular function in adults with metabolic syndrome.

What is being tested

Sponsor: Mayo Clinic · Participants: 40 · Started: Apr 13, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07401888

Locations in the U.S.

MinnesotaMayo Clinic in Rochester, Rochester

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.